Literature DB >> 28639906

Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.

Hao-Jie Yang1, Jing-Hang Jiang2, Qing-An Liu1, Cheng-Mao Zhou3, Yang-Feng Du4, Tao Wu4, Neng-Zhi Chen1, Bang-De Xiang5.   

Abstract

The Platelet to lymphocyte ratio (PLR) has been reported to predict prognosis of patients with hepatocellular carcinoma (HCC). This study examined the prognostic potential of stratified PLR for HCC patients undergoing curative liver resection. Medical records were retrospectively analyzed for 778 HCC patients undergoing curative liver resection at the Affiliated Tumor Hospital of Guangxi Medical University and the First People's Hospital of Changde between April 2010 and October 2013. Patients were stratified based on quintile analysis of their preoperative PLR, and patients in different quintiles were analyzed for overall survival (OS) and disease-free survival (DFS) using Kaplan-Meier analysis. Independent predictors of death or recurrence were explored using multivariable Cox proportional hazard regression. Higher PLR quintiles were significantly associated with poorer overall survival (p < 0.001). Multivariate analysis showed PLR to be an independent risk factor for OS (p = 0.003). Patients in PLR quintile 5 had lower overall survival than in quintile 1 (hazard ratio (HR) = 2.780, 95% confidence interval (CI): 1.769-4.367, p < 0.001). Although patients in PLR quintile 5 had significantly lower disease-free survival (DFS) than in quintile 1 (HR = 1.534, 95% CI: 1.112-2.117, p = 0.009), this association was not significant after multivariable adjustment (p = 0.220). Subgroup analysis also showed that PLR quintiles were significantly associated with poor OS in patients positive for HBsAg or with cirrhosis (both p < 0.001). Similar results were obtained when PLR was analyzed as a dichotomous variable with cut-off values of 110 and 115. Elevated preoperative PLR may be independently associated with poor OS and DFS in HCC patients following curative resection.

Entities:  

Keywords:  Platelet-to-lymphocyte ratio; curative liver resection; hepatocellular carcinoma; overall survival; recurrence

Mesh:

Substances:

Year:  2017        PMID: 28639906     DOI: 10.1177/1010428317707375

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  11 in total

1.  Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma.

Authors:  Yuxin Guo; Darren W Chua; Ye-Xin Koh; Ser-Yee Lee; Peng-Chung Cheow; Juinn-Huar Kam; Jin-Yao Teo; Pierce K Chow; Alexander Y Chung; London L Ooi; Chung-Yip Chan; Brian K P Goh
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Authors:  Bernhard Scheiner; Martha Kirstein; Sabine Popp; Florian Hucke; Simona Bota; Nataliya Rohr-Udilova; Thomas Reiberger; Christian Müller; Michael Trauner; Markus Peck-Radosavljevic; Arndt Vogel; Wolfgang Sieghart; Matthias Pinter
Journal:  Liver Cancer       Date:  2018-06-22       Impact factor: 11.740

3.  Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma.

Authors:  Yuchen Wang; Bashar M Attar; Harry E Fuentes; Palashkumar Jaiswal; Alfonso J Tafur
Journal:  J Gastrointest Oncol       Date:  2017-12

4.  Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.

Authors:  Jinming Yu; Zhaoyan Ding; Yuanming Yang; Shanli Liu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 5.  Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis.

Authors:  Wan-Fu Lin; Mao-Feng Zhong; Yu-Ren Zhang; Huan Wang; He-Tong Zhao; Bin-Bin Cheng; Chang-Quan Ling
Journal:  Gastroenterol Res Pract       Date:  2018-08-08       Impact factor: 2.260

6.  Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma.

Authors:  T Kabir; M Ye; N A Mohd Noor; W Woon; S P Junnarkar; V G Shelat
Journal:  Int J Hepatol       Date:  2019-04-02

7.  Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.

Authors:  Agata Michalak; Halina Cichoż-Lach; Małgorzata Guz; Joanna Kozicka; Marek Cybulski; Witold Jeleniewicz; Andrzej Stepulak
Journal:  World J Gastroenterol       Date:  2020-12-21       Impact factor: 5.742

8.  Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy.

Authors:  Michihito Toda; Takuma Tsukioka; Nobuhiro Izumi; Hiroaki Komatsu; Satoshi Okada; Kantaro Hara; Hikaru Miyamoto; Ryuichi Ito; Toshihiko Shibata; Noritoshi Nishiyama
Journal:  Thorac Cancer       Date:  2017-11-03       Impact factor: 3.500

9.  Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.

Authors:  Aslı Suner; Brian I Carr; Hikmet Akkiz; Oguz Uskudar; Sedef Kuran; Yaman Tokat; Salih Tokmak; Tugsan Ballı; Abdulalh Ulku; Tolga AkCam; Anıl Delik; Burcu Arslan; Figen Doran; Kendal YalCın; Nazım Ekinci; Sezai Yilmaz; Ayşegul Ozakyol; Mehmet Yücesoy; Halil Ibrahim BahCeci; Kamil Yalcın Polat; Halis Şimsek; Necati Ormeci; Abdulalh Sonsuz; Mehmet Demir; Murat KılıC; Ahmet Uygun; Ali Demir; Engin Altıntas; Gokhan Karakulah; Tuncer Temel; Ahmet Bektas
Journal:  J Transl Sci       Date:  2018-06-22

10.  Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.

Authors:  Yuxin Guo; Ek-Khoon Tan; Nicholas L Syn; Thinesh-Lee Krishnamoorthy; Chee-Kiat Tan; Reina Lim; Ser-Yee Lee; Chung-Yip Chan; Peng-Chung Cheow; Alexander Y F Chung; Prema Raj Jeyaraj; Brian K P Goh
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.